47.73.Z - Retail sale of pharmaceutical products
47.19.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
47.99.Z - Retail trade
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
68.31.Z - Real estate brokerage
68.32.Z - Other real estate activities on behalf of third parties
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,1 | 0,1 | 0,6 | 669,7 |
EBITDA | 0,1 | 0,1 | 0,6 | 500,2 |
Short time liabilities | 0,1 | 0 | 2,3 | 50 270,4 |
Equity capital | 0,7 | 0,8 | 1,4 | 68,9 |
Operating profit (EBIT) | 0,1 | 0,1 | 0,6 | 655 |
Assets | 0,8 | 0,8 | 4,3 | 429,6 |
Net profit (loss) | 0,1 | 0,1 | 0,6 | 671,3 |
Cash | 0 | 0 | 0,3 | 919,3 |
Liabilities and provisions for liabilities | 0,1 | 0 | 2,9 | 63 245,4 |
Net income from sale | 0,1 | 0,1 | 1,3 | 869,6 |
Working assets | 0 | 0 | 2,1 | 5983,1 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 12,5 | 8,9 | 40,8 | 31,9 |
Equity capital to total assets | 90,9 | 99,4 | 31,7 | -67,7 |
Gross profit margin | 73,1 | 57,4 | 45,5 | -11,9 |
EBITDA Margin | 94,8 | 76,5 | 47,3 | -29,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 195 | 12 | 637 | 625 |
Current financial liquidity indicator | 0.07758932560682297 | 7.282544136047363 | 0.8794952630996704 | -6,4 |
Net dept to EBITDA | 0.4936442971229553 | -0.3095623254776001 | 4.107521057128906 | 4,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane